argenx (ARGX) News Today $640.52 -19.29 (-2.92%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Oak Ridge Investments LLC Trims Stock Holdings in argenx SE (NASDAQ:ARGX)Oak Ridge Investments LLC decreased its stake in shares of argenx SE (NASDAQ:ARGX - Free Report) by 60.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,769 shares of the company's stock after selling 2,696 shares during the period.January 19 at 7:33 AM | marketbeat.comDeutsche Bank Aktiengesellschaft Downgrades argenx (NASDAQ:ARGX) to SellJanuary 19 at 3:02 AM | americanbankingnews.comHC Wainwright Has Strong Forecast for argenx FY2024 EarningsJanuary 19 at 2:15 AM | americanbankingnews.comAssenagon Asset Management S.A. Acquires 6,161 Shares of argenx SE (NASDAQ:ARGX)Assenagon Asset Management S.A. boosted its holdings in shares of argenx SE (NASDAQ:ARGX - Free Report) by 21.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,955 shares of the company's stock after acqJanuary 18 at 3:40 AM | marketbeat.comWedbush Comments on argenx's Q4 Earnings (NASDAQ:ARGX)January 18 at 2:15 AM | americanbankingnews.comArgenx downgraded to Sell from Hold at Deutsche BankJanuary 17 at 6:53 PM | markets.businessinsider.comArgenx downgraded to Sell at Deutsche Bank on unfavorable risk/rewardJanuary 17 at 6:53 PM | markets.businessinsider.comArgenx cut to Sell at Deutsche Bank on valuationJanuary 17 at 6:53 PM | msn.comargenx (NASDAQ:ARGX) Downgraded by Deutsche Bank Aktiengesellschaft to "Sell"Deutsche Bank Aktiengesellschaft lowered argenx from a "hold" rating to a "sell" rating in a research note on Friday.January 17 at 2:27 PM | marketbeat.comWhat is HC Wainwright's Forecast for argenx FY2024 Earnings?argenx SE (NASDAQ:ARGX - Free Report) - Stock analysts at HC Wainwright raised their FY2024 earnings per share (EPS) estimates for argenx in a research note issued to investors on Tuesday, January 14th. HC Wainwright analyst D. Tsao now anticipates that the company will post earnings of $2.30 perJanuary 17 at 7:05 AM | marketbeat.comargenx SE (NASDAQ:ARGX) Given Average Rating of "Moderate Buy" by AnalystsJanuary 17 at 3:18 AM | americanbankingnews.comargenx SE (NASDAQ:ARGX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of argenx SE (NASDAQ:ARGX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty-two ratings firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, eighteen have assignedJanuary 17 at 3:17 AM | marketbeat.comWedbush Brokers Increase Earnings Estimates for argenxargenx SE (NASDAQ:ARGX - Free Report) - Research analysts at Wedbush raised their Q4 2024 EPS estimates for argenx in a note issued to investors on Monday, January 13th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of $2.74 per share for the quarter, up from tJanuary 16, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for argenx (NASDAQ:ARGX)January 16, 2025 | americanbankingnews.comArgenx Se: Strong Financial Performance and Strategic Advancements Justify Buy RatingJanuary 15, 2025 | markets.businessinsider.comArgenx price target raised to $717 from $670 at H.C. WainwrightJanuary 15, 2025 | markets.businessinsider.comArgenx price target raised to $700 from $660 at TruistJanuary 14, 2025 | markets.businessinsider.comL'objectif de cours de l'action Argenx relevé à 717 dollars par H.C. WainwrightJanuary 14, 2025 | fr.investing.comUBS Remains a Hold on Argenx Se (ARGX)January 14, 2025 | markets.businessinsider.comArgenx price target raised to $696 from $606 at JMP SecuritiesJanuary 14, 2025 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for argenx (NASDAQ:ARGX)HC Wainwright restated a "buy" rating and set a $717.00 price target (up previously from $670.00) on shares of argenx in a research note on Tuesday.January 14, 2025 | marketbeat.comargenx (NASDAQ:ARGX) Given Buy Rating at Truist FinancialTruist Financial restated a "buy" rating and issued a $700.00 price target (up from $660.00) on shares of argenx in a research note on Tuesday.January 14, 2025 | marketbeat.comargenx (NASDAQ:ARGX) Given New $696.00 Price Target at JMP SecuritiesJMP Securities upped their price objective on argenx from $606.00 to $696.00 and gave the company a "market outperform" rating in a research report on Tuesday.January 14, 2025 | marketbeat.comArgenx Se: Strong Financial Performance and Promising Growth Prospects Justify Buy RatingJanuary 13, 2025 | markets.businessinsider.comargenx (NASDAQ:ARGX) Sets New 12-Month High - What's Next?argenx (NASDAQ:ARGX) Reaches New 52-Week High - Still a Buy?January 13, 2025 | marketbeat.comargenx SE: argenx Highlights 2025 Strategic PrioritiesJanuary 13, 2025 | finanznachrichten.deArgenx reports preliminary Q4 revenue $737M, consensus $627.99MJanuary 13, 2025 | markets.businessinsider.comArgenx sees FY24 revenue $2.2B, consensus $2.01BJanuary 13, 2025 | markets.businessinsider.comargenx Highlights 2025 Strategic PrioritiesJanuary 13, 2025 | globenewswire.comPiper Sandler Remains a Buy on Argenx Se (ARGX)January 7, 2025 | markets.businessinsider.comArgenx price target raised to $761 from $717 at BofAJanuary 7, 2025 | markets.businessinsider.comargenx (NASDAQ:ARGX) Given New $725.00 Price Target at Piper SandlerPiper Sandler lifted their price target on argenx from $620.00 to $725.00 and gave the stock an "overweight" rating in a report on Tuesday.January 7, 2025 | marketbeat.comargenx (NASDAQ:ARGX) Reaches New 12-Month High - Still a Buy?argenx (NASDAQ:ARGX) Sets New 1-Year High - What's Next?January 6, 2025 | marketbeat.comargenx SE (ARGX) to Present at J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | gurufocus.comargenx SE (ARGX) to Present at J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | gurufocus.comargenx to Present at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comCentral Pacific Bank Trust Division Acquires Shares of 1,000 argenx SE (NASDAQ:ARGX)Central Pacific Bank Trust Division bought a new position in argenx SE (NASDAQ:ARGX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,000 shares of the company's stock, valued at approximately $615,000. Several oJanuary 4, 2025 | marketbeat.comHalozyme announces Vyvdura co-formulated with Enhanze granted MHLW approvalDecember 31, 2024 | markets.businessinsider.comWedbush Forecasts argenx's Q2 Earnings (NASDAQ:ARGX)argenx SE (NASDAQ:ARGX - Free Report) - Research analysts at Wedbush upped their Q2 2025 earnings estimates for shares of argenx in a research report issued on Friday, December 27th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of $2.26 per share for the quaDecember 30, 2024 | marketbeat.comArgenx announces Japan MHLW approval for Vyvdura for CIDPDecember 27, 2024 | markets.businessinsider.comArgenx's VYVDURA Approved In Japan For Chronic Inflammatory Demyelinating PolyneuropathyDecember 27, 2024 | markets.businessinsider.comargenx SE (ARGX) Gains Approval for VYVDURA in Japan for CIDP TreatmentDecember 27, 2024 | gurufocus.comargenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating PolyneuropathyDecember 27, 2024 | globenewswire.comIs Argenx SE (ARGX) the Best Performing Biotech Stock in 2024?December 23, 2024 | msn.comargenx SE (NASDAQ:ARGX) Receives Average Rating of "Moderate Buy" from Brokeragesargenx SE (NASDAQ:ARGX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-two ratings firms that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy ratingDecember 23, 2024 | marketbeat.comArgenx price target raised to $723 from $639 at Wells FargoDecember 20, 2024 | markets.businessinsider.comWells Fargo & Company Increases argenx (NASDAQ:ARGX) Price Target to $723.00Wells Fargo & Company raised their price target on shares of argenx from $639.00 to $723.00 and gave the stock an "overweight" rating in a research note on Thursday.December 19, 2024 | marketbeat.comArgenx Se (ARGX) Gets a Hold from UBSDecember 19, 2024 | markets.businessinsider.comArgenx Se: Promising Growth with Strategic Expansion and Clinical AdvancementsDecember 18, 2024 | markets.businessinsider.comL'action d'Argenx atteint un sommet historique de 630,4$ sur fond de croissance robusteDecember 17, 2024 | fr.investing.com Get argenx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address ARGX Media Mentions By Week ARGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARGX News Sentiment▼0.440.44▲Average Medical News Sentiment ARGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARGX Articles This Week▼358▲ARGX Articles Average Week Get argenx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News GSK News TAK News BNTX News TEVA News BGNE News GMAB News VTRS News ITCI News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARGX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding argenx SE Please log in to your account or sign up in order to add this asset to your watchlist. Share argenx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
